Transpact Enterprises Ltd.
Snapshot View

View in App

Prices View details

160.60 ▼0%

14 July 2021, 04:00:00 P.M.

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.transpact.in
Financial Indicators
Market Cap 6.21 Cr.
Earnings per share (EPS) -1.65 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 118.36 Trailing Twelve Months Ending 2021-03
Book Value / Share 21.20 Trailing Twelve Months Ending 2021-03
Price to Book Value 7.58 Calculated using Price: 160.60
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.04 Cr. 386,730 Shares
FaceValue 10
Company Profile

Transpact Enterprises was incorporated as Transpact Enterprises Private Limited on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The certificate of incorporation was issued on May 12, 2013 by the Registrar of Companies, Mumbai at Maharashtra. Further the status of the Company was changed to public limited Company and the name of the company was changed to Transpact Enterprises Limited by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019, by the Registrar of Companies, Mumbai.

Business area of the company

Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Milestones:

  • May 2013: Incorporated as 'Transpact Enterprises Private Limited'
  • June 2015: Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator
  • December 2015: Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.
  • September 2016: Received ISO 9001:2015 certification for quality management system
  • October 2016: Received 13485:2016 certification for 'Medical devices'.
  • March 2018: Assessed and registered as compliance as per the requirements of Council Directive- Medical Devices Directive– 2007/47/EC by International Standards Registrations.
  • March 2019: Conversion of Private Company ' Transpact Enterprises Private Limited' to Public Company 'Transpact Enterprises Limited'.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
1 Month
-0.86%
3 Month
+4.29%
6 Month
+13.10%
1 Year
+18.96%
2 Year
5 Year

Ratios View Details

4 years 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -27.59 -77.28 -804.02 -97.83
Return on Capital Employed (%) -19.45 -27.62 -66.20 -53.57
Return on Assets (%) -19.19 -25.93 -60.34 -47.48

Balance Sheet View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 0 0 0 1
Non Curr. Liab. 0 0
Curr. Liab. 0 0 0 0
Minority Int.
Equity & Liab. 0 0 1 1
Non Curr. Assets 0 0 0 1
Curr. Assets 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 1 1

Profit Loss View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 0
Other Income 0
Total Income 0 0
Total Expenditure 0 0 0 0
PBIDT 0 0 0 0
Interest
Depreciation 0 0
Taxation 0 0
Exceptional Items
PAT 0 0 0 0

Cash Flow View Details

Particulars 4 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 1
Net Change 0 0
Cash & Cash Eqvt 0 0 0 0

Shareholding Pattern View Details

4 Qtrs 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%)
Promoter 45.89 45.89 45.89 45.89
Public 54.11 54.11 54.11 54.11
Depository Receipts 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 20 Jul 2021
Disclosure Pursuant To SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated<BR> November 26 2018 Fund Raising By Issuance Of Debt Securities By Large Entities.
With reference to the SEBI circular mentioned in caption in the matter of Fund raising by issuance of Debt Securities by Large Entities specifically mandating certain disclosure to the Exchange(s) by the listed entity (viz. Large Corporate- LC) as mentioned in para 4 of the circular fulfilling the
criteria specified in such circular in para 2.2 of the circular.
In connection with the same we confirm that our Company is not falling under Large Corporate (LC) category as per the framework provided in the circular.
Request you to take the same on your records.
Fri, 16 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We hereby enclose a certificate under regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2021 received from M/s. Bigshare Services Pvt. Ltd Registrar and Share Transfer Agent of our company.
Request you to take the same on your records.
Wed, 14 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Mohammed Aslam Khan
Designation :- Managing Director / Whole Time Director

Technical Scans View Details

No Scans Found

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 154,127.39 1,400.25 +0.0%
Adani Transmission Ltd. 103,690.09 933.85 -0.5%
Sundram Fasteners Ltd. 15,707.10 749.25 +2.2%
Redington (India) Ltd. 12,689.89 324.70 +1.5%
MMTC Ltd. 7,597.50 50.65 -0.7%
Novartis India Ltd. 2,318.59 938.25 -0.5%
MSTC Ltd. 2,031.04 288.00 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 167.05 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 84.71 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 43.73 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 16.78 324.70 +1.5%
MMTC Ltd. Standalone 2020-12 0.00 50.65 -0.7%
Novartis India Ltd. Standalone 2021-03 110.94 938.25 -0.5%
MSTC Ltd. Consolidated 2021-03 17.98 288.00 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 8.98 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 17.03 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 6.69 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 2.57 324.70 +1.5%
MMTC Ltd. Standalone 2020-12 7.52 50.65 -0.7%
Novartis India Ltd. Standalone 2021-03 3.26 938.25 -0.5%
MSTC Ltd. Consolidated 2021-03 3.64 288.00 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 4.89 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 0.09 324.70 +1.5%
MMTC Ltd. Standalone 2020-03 4.23 50.65 -0.7%
Novartis India Ltd. Standalone 2020-03 0.00 938.25 -0.5%
MSTC Ltd. Consolidated 2020-03 0.55 288.00 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 22.81 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 17.02 324.70 +1.5%
MMTC Ltd. Standalone 2020-03 -20.23 50.65 -0.7%
Novartis India Ltd. Standalone 2020-03 1.36 938.25 -0.5%
MSTC Ltd. Consolidated 2020-03 23.14 288.00 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 10.89 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 21.81 324.70 +1.5%
MMTC Ltd. Standalone 2020-03 -2.16 50.65 -0.7%
Novartis India Ltd. Standalone 2020-03 4.73 938.25 -0.5%
MSTC Ltd. Consolidated 2020-03 22.93 288.00 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 324.70 +1.5%
MMTC Ltd. Standalone 2020-03 26,304.71 50.65 -0.7%
Novartis India Ltd. Standalone 2020-03 438.25 938.25 -0.5%
MSTC Ltd. Consolidated 2020-03 1,231.40 288.00 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,400.25 +0.0%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 933.85 -0.5%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 749.25 +2.2%
Redington (India) Ltd. Consolidated 2021-03 786.61 324.70 +1.5%
MMTC Ltd. Standalone 2020-03 -220.48 50.65 -0.7%
Novartis India Ltd. Standalone 2020-03 10.08 938.25 -0.5%
MSTC Ltd. Consolidated 2020-03 99.71 288.00 +1.8%